|
|
||||||||
Ann Thorac Surg 1998;65:212-216
© 1998 The Society of Thoracic Surgeons
Department of Pulmonology, Sint Antonius Hospital, Nieuwegein, the Netherlands
Department of Thoracic Surgery, Sint Antonius Hospital, Nieuwegein, the Netherlands
Department of Pathology, Sint Antonius Hospital, Nieuwegein, the Netherlands
Accepted for publication July 23, 1997.
Dr Snijder, Department of Pulmonology, Sint Antonius Hospital, PO Box 2500, 3430 EM Nieuwegein, the Netherlands.
Background. Sometimes microscopic residual tumor is found at the bronchial resection margin despite an apparently complete resection of lung cancer. This may adversely affect the patients prognosis. Its impact on survival is unclear.
Methods. The records of 834 patients with resected stage I nonsmall cell lung cancer were studied. Patients with complete resection were assigned to the complete resection group (n = 802); patients with microscopic residual tumor at the bronchial resection margin that was accepted were assigned to the residual tumor group (n = 23). Residual tumor was classified as carcinoma in situ, mucosal residual disease, or peribronchial residual disease.
Results. The 5-year survival in the patients in the complete resection group was 54%; it was 58% in the residual tumor group with carcinoma in situ and 27.3% in the residual tumor group with invasive tumor (mucosal residual disease or peribronchial residual disease). The difference in survival between patients in the complete resection group and patients in the residual tumor group with invasive tumor was significant (p = 0.03).
Conclusions. The presence of mucosal or peribronchial residual disease, but not carcinoma in situ, at the bronchial resection margin in patients with stage I nonsmall cell lung cancer has an adverse effect on survival.
This article has been cited by other articles:
![]() |
E. Fernandez, P. L. de Castro, J. Astudillo, J. Fernandez-Llamazares, and and GCCB-S (Bronchogenic Carcinoma Cooperative Gro Bronchial stump infiltration after lung cancer surgery. Retrospective study of a series of 2994 patients Interactive CardioVascular and Thoracic Surgery, August 1, 2009; 9(2): 182 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Collaud, M. Bongiovanni, J.-C. Pache, G. Fioretta, and J. H. Robert Survival according to the site of bronchial microscopic residual disease after lung resection for non-small cell lung cancer. J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 622 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wind, E. J. Smit, S. Senan, and J.-P. Eerenberg Residual disease at the bronchial stump after curative resection for lung cancer Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 29 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Little, V. W. Rusch, J. A. Bonner, L. E. Gaspar, M. R. Green, W. R. Webb, and A. K. Stewart Patterns of Surgical Care of Lung Cancer Patients Ann. Thorac. Surg., December 1, 2005; 80(6): 2051 - 2056. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Balasubramanian, J. Au, and J. Dunning Should lobectomy patients with microscopic involvement of the bronchial resection margin undergo re-operation to improve their long-term survival? Interactive CardioVascular and Thoracic Surgery, December 1, 2005; 4(6): 531 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rami-Porta, M. Mateu-Navarro, J. Freixinet, M. de la Torre, A. Jose Torres-Garcia, Y.-W. Pun, A. Canto Armengod, and on behalf of the Bronchogenic Carcinoma Cooperativ Type of resection and prognosis in lung cancer. Experience of a multicentre study Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 622 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pasic, K. Grunberg, W. J. Mooi, M. A. Paul, P. E. Postmus, and T. G. Sutedja The Natural History of Carcinoma In Situ Involving Bronchial Resection Margins Chest, September 1, 2005; 128(3): 1736 - 1741. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ruffini, M. Bongiovanni, A. Cavallo, P.L. Filosso, R. Giobbe, M. Mancuso, M. Molinatti, and A. Oliaro The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms Eur. J. Cardiothorac. Surg., July 1, 2004; 26(1): 165 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Humphrey, S. Teutsch, and M. Johnson Lung Cancer Screening with Sputum Cytologic Examination, Chest Radiography, and Computed Tomography: An Update for the U.S. Preventive Services Task Force Ann Intern Med, May 4, 2004; 140(9): 740 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lequaglie, B. Conti, P.P. Brega Massone, and G. Giudice Unsuspected residual disease at the resection margin after surgery for lung cancer: fate of patients after long-term follow-up Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 229 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kara, E. Dikmen, D. Kilic, S. Dizbay Sak, D. Orhan, S. K. Kose, and S. Kavukcu Prognostic implications of microscopic proximal bronchial extension in non-small cell lung cancer Ann. Thorac. Surg., August 1, 2002; 74(2): 348 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.S. Hofmann, C. Taege, C. Lautenschlager, H. Neef, and R.E. Silber Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancer Eur. J. Cardiothorac. Surg., April 1, 2002; 21(4): 606 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Passlick, I. Sitar, W. Sienel, O. Thetter, and A. Morresi-Hauf Significance of lymphangiosis carcinomatosa at the bronchial resection margin in patients with non-small cell lung cancer Ann. Thorac. Surg., October 1, 2001; 72(4): 1160 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kara, S. Dizbay Sak, D. Orhan, and S. Kavukcu Proximal bronchial extension with special reference to tumor localization in non-small cell lung cancer Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 350 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Mitchell, D. J. Mathisen, C. D. Wright, J. C. Wain, D. M. Donahue, J. S. Allan, A. C. Moncure, and H. C. Grillo Resection for bronchogenic carcinoma involving the carina: Long-term results and effect of nodal status on outcome J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 465 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fujimoto, G. Zaboura, S. Fechner, L. Hillejan, T. Schroder, A. Marra, T. Krbek, M. Hinterthaner, D. Greschuchna, and G. Stamatis Completion pneumonectomy: Current indications, complications, and results J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 484 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Massard, C. Doddoli, B. Gasser, X. Ducrocq, R. Kessler, C. Schumacher, G.-M. Jung, and J.-M. Wihlm Prognostic implications of a positive bronchial resection margin Eur. J. Cardiothorac. Surg., May 1, 2000; 17(5): 557 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Barnes Bronchial Arterial Infusion for Lung Cancer Chest, May 1, 2000; 117(5): 1525 - 1525. [Full Text] [PDF] |
||||
![]() |
C. Ghiribelli, L. Voltolini, P. Paladini, L. Luzzi, M. Di Bisceglie, and G. Gotti Treatment and survival after lung resection for non-small cell lung cancer in patients with microscopic residual disease at the bronchial stump Eur. J. Cardiothorac. Surg., November 1, 1999; 16(5): 555 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Massard, R. Kessler, B. Gasser, X. Ducrocq, S. Elia, S. Gouzou, and J.-M. Wihlm Local control of disease and survival following bronchoplastic lobectomy for non-small cell lung cancer Eur. J. Cardiothorac. Surg., September 1, 1999; 16(3): 276 - 282. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |